Objective. To establish the intracellular consequences of electrical stimulation to spiral ganglion neurons after deafferentation. Here we use a rat model to determine the effect of both low and high pulse rate acute electrical stimulation on activation of the proapoptotic transcription factor Jun in deafferented spiral ganglion neurons in vivo.
Introduction
Cochlear hair cells are the sole afferent input to spiral ganglion neurons (SGNs) and provide neurotrophic support. Hair cell death and dysfunction are the primary etiologies for human sensorineural hearing loss. After deafferentation, SGNs degenerate and die over a period of time ranging from months in rats, [1] [2] [3] to years in cats, 4 to decades in humans. 5, 6 Cochlear implants (CIs) bypass the hair cell auditory transduction mechanism by providing direct depolarizing electrical stimulation (ES) to SGNs. Thus, the death of SGN cells and loss of dendrites are potentially limiting factors for the transmission of auditory information from CIs to the central nervous system.
Although positive correlation between speech performance and SGN survival has not been demonstrated in cochlear implantees, 7 electrophysiological and psychophysical parameters in cochlear implantees are correlated with SGN survival in animal studies, 8 human subjects, 9, 10 and computational models. 11 Thus, prevention of SGN degeneration, apoptosis, or loss of dendrites may enhance the benefits of CIs and improve auditory outcomes.
Although chronic depolarization is an effective trophic stimulus for SGNs in vitro, 12 studies differ regarding the ability of ES via an implanted electrode to prevent SGN death in vivo. [13] [14] [15] [16] [17] However, a survival-promoting effect of ES in vivo can be revealed when it is administered in combination with intracochlear infusion of neurotrophic factors. 18 To investigate the mechanism of potential anti-apoptotic effects of ES, we directly assessed apoptosis-related intracellular signaling by monitoring phosphorylation of the nuclear transcription factor Jun by the MAP kinase c-Jun N-terminal Kinase (JNK), an event known to occur in apoptotic neurons 19 and to be necessary for neuronal apoptosis. 20 Our previous studies have established that the proapoptotic JNK-Jun signaling pathway is active in SGNs after deafferentation and is correlated with apoptosis. 21 Thus, we used immunofluorescent (IF) detection of phosphorylated Jun (pJun) in SGN nuclei as a reporter for apoptotic signaling in vivo. We asked whether ES suppresses Jun phosphorylation and, to the extent that it does so, what are the consequences of factors that may affect SGN survival after deafferentation: duration of deafness, proximity of the stimulating electrode to SGN somata, and pulse rate.
Methods
All protocols were approved by the University of Iowa Institutional Animal Use and Care Committee. Test rats were chemically deafened from postnatal day 8 (P8) to P16 using daily intraperitoneal injection of kanamycin (400 mg/ kg, Apothecon). 22 Profound hearing loss was tested by click auditory brainstem response (ABR) at P21 to exclude rats from any further study. Hair cell loss was definitively confirmed in the cochleae used for phosphoJun quantification by lack of calretinin IF (a marker of inner hair cells). Four nonconsecutive sections from each subject were labeled with anticalretinin to exclude subjects with any surviving inner hair cells.
As shown in Table 1 , 24 deafened rats underwent unilateral cochlear implantation at either P32 or P60, of which 3 at either age received no ES. Controls included the nonoperated contralateral cochleae; age-matched, unoperated deafened rats; and age-matched hearing rats both operative and nonanesthetized unoperated. These numbers, summarized in Table 1 , are comparable to those used in a previous study (Alam et al 21 ) showing Jun phosphorylation in deafened rats.
Rats were anesthetized using intramuscular Ketamine (90 mg/kg)/Xylazine (10 mg/kg) injection. Ketamine (45 mg/ kg) was subsequently injected as needed to maintain surgical plane per pedal and blink reflexes. Ventral tracheotomy was performed and a Harvard Rodent Ventilator was used throughout the 4-hour stimulation period. A dorsal approach was used to open the bulla and access the round window as previously described 23, 24 (Figure 1, upper panel) .
The electrically evoked auditory brainstem response (eABR) was recorded to verify neurological responses. Subdermal needle electrodes were placed at the vertex (common positive), contralateral nuchal skin (ground), and sternocleidomastoid muscle adjacent to the test ear ( Figure 1 , upper panel). The electrode, a Teflon-insulated platinum/iridium wire with 1 mm of its tip stripped of insulation, was inserted via the round window cochleostomy 1 to 3 mm into the scala tympani. The return electrode for monopolar stimulation was placed in the left forepaw. 25 eABRs were recorded directly after electrode implantation to determine electrically evoked response thresholds and again after completion of ES. Figure 1 lower panels diagram the electrical stimulation current patterns for the ES protocols: low rate (100 Hz) ES was 100 ms biphasic pulses with an interpulse interval of 9.92 ms; high rate (5 kHz) ES was 100 ms biphasic pulses with an interpulse interval of 100 ms. The stimulating current amplitude was twice eABR threshold (typically 0.5-1.2 mA) with threshold defined as the current amplitude that evoked a 1 V or greater replicable waveform. Control hearing and deafened animals underwent surgery, electrode insertion, and maintenance of 4 hours in surgical plane anesthesia without ES.
After 4 hours of continuous ES, eABR threshold and growth function recordings were repeated. Still in surgical plane, the animals were then euthanized by transcardial perfusion with phosphate-buffered saline (PBS), followed by 4% paraformaldehyde (PFA). Cochleae were further fixed by intrascalar perfusion with 0.5 ml PBS/4% PFA gently injected into the round window. Cochleae were then placed in PBS/4% PFA for 24 hours at 4°C with rotation. After rinsing for 24 hours with PBS, the cochleae were decalcified in 0.12 M EDTA for 7 days at 4°C. In preparation for sectioning, cochleae underwent infiltration with a graded series of sucrose solutions to 30% and then infiltration under gentle vacuum with degassed and heated OCT118. 26 After 24 hours, the cochleae were embedded in OCT and frozen for cryosectioning. Serial 6 mm sections parallel to the midmodiolar plane were cut on a Leica freezing microtome and placed on polylysine-coated Fisher Superfrost slides.
Immunohistochemistry was performed as described previously. 21 Rabbit anti-pJun (1:400, Cell Signaling) was used to label nuclei with phosphorylated Jun and combined mouse antibodies to 200 kDa neurofilament (NF200, 1:400, Sigma), b3 tubulin (TuJ1, 1:400, Abcam), and 150 kDa neurofilament 2H3 (1:400, Developmental Studies Hybridoma Bank) to label neurons and their axons. Sections used for pJun labeling were also labeled with all 3 antineuronal antibodies. Adjacent sections were labeled with rabbit anti-calretinin (1:400, Millipore, formerly Chemicon) to label any surviving inner hair cells. Fluorescently labeled anti-rabbit (for calretinin, pJun) and anti-mouse (for neurons) secondary antibodies (Alexa dyes, Molecular Probes) were then applied. After a wash with PBS, the sections were stained with Hoechst 33342 to label nuclei and coverslipped. Tissue sections were viewed on a Zeiss Axiovert 200 microscope. Images of control and experimental sections were captured in the same session using identical settings to allow quantitative comparison. Each image was assigned a random number irrelevant to the experimental condition; thus, subsequent analyses were performed by a person blind to the experimental conditions. NIH ImageJ software was used to quantify pJun IF and to correct each nucleus individually for local cytoplasmic or background fluorescence.
Nuclear pJun quantitative immunofluorescence at each cochlear location was compared among subjects for all spiral ganglion neurons scored. Cochlear location was defined by half-turn increments proceeding from base to apex, starting at the basal-most half-turn (adjacent to the round window and inserted electrode)-indicated by Rosenthal Canal 1 (RC1) and proceeding apically to RC4 ( Figure 2 ). For any given turn (RC), 3 to 4 perimodiolar sections were used to quantify pJun IF level. All neurons within each section were sampled and averaged for each RC. pJun IF averages for all cells of a given cochlea included all cells from RC1, RC2, and RC3. SGNs in RC4 were excluded as some subjects had surviving calretininpositive hair cells in or adjacent to the helicotrema. Values for IF are in arbitrary optical density units consistent among all subjects and replicates. N is defined as the number of cochleae in each subgroup. This number is given in each column in the following figures in cases where n differs among the columns. All figures show mean 6 standard error of the mean (SEM).
Nonparametric tests were used to compare groups. In most cases, two-sample t tests with a Satterthwaite adjustment for unequal variances agreed with the nonparametric tests. We also report the effect size value h 2 from the t test that measures the percentage of variance in the outcome variable, which is explained by the difference between the 2 groups being compared.
Results
Rats at P32 and at P60 were implanted with electrodes for 4 hours of ES at 100 or 5000 Hz and then euthanized. These 2 ages were chosen based on our previous data (Alam et al 21 ) showing that P32 is the earliest time point at which a significant reduction in SGN death can be observed and P60 is the time point at which about half of the SGNs have died. Thus, we are assessing the effect of ES on proapoptotic signaling in ears both at an early stage post-deafening when most SGNs are still alive (P32) and at a later stage when neuronal degeneration is well advanced (P60).
Consistent with the previous results of Alam et al 21 we observed increased pJun IF in the basal turn of deafened rats at P32; moreover, the pJun IF was reduced by ES. Figure 3 shows examples of RC1 pJun IF in electrically stimulated cochleae, at 100 and 5 kHz (upper panels) and the contralateral unstimulated cochlea from the same rat (lower panels). PhosphoJun (nuclear) is labeled green with anti-rabbit IgG and the combined mouse antibodies detecting neurons-NF200, TuJ1, and 2H3-are labeled red with anti-mouse IgG. A striking feature of pJun IF was the high degree of heterogeneity among SGNs within each subject, evident from the high SEM. For example, the cochlear positions in subject R21 had pJun quantitative immunofluorescence (qIF) values: RC1, 16.76 9.9 (SEM); RC2, 13.5 6 7.8; RC3, 13.1 6 7.6; all, 14.3 6 8.5. This is consistent with previous observations after deafening 1, 21 in that at any one time, only some rat SGNs in a section exhibit elevated pJun. There was also variability among rats, so change in pJun qIF due to ES in each rat was determined relative to the contralateral unstimulated cochlea.
Excluding the electrically stimulated rats, we observed an increase in Jun phosphorylation in all deafened ears relative to all age-matched hearing controls. That is, SGNS in RC1 in cochleae from all deafened unstimulated rats have significantly higher pJun qIF than do RC1 SGNs in control hearing cochleae ( Figure 4A , Mann-Whitney U test, P = .012, h 2 = 0.17). The increase was significant only in the basal-most region (RC1) of the spiral ganglion. The increase in pJun qIF in RC1 SGNs was also significant when the comparison was limited just to the subset of nonoperative controls ( Figure 4B , Mann-Whitney U test, P = .016, h 2 = 0.23). These data confirm the results of Alam et al 21 and are consistent with studies showing the cochlea base to be more susceptible to aminoglycoside ototoxicity. 27 We next asked whether ES suppresses Jun phosphorylation in SGNs and whether this effect is dependent on deafness duration. Combining data from all unstimulated deafened cochleae, age alone had no significant effect on pJun qIF ( Figure 5A) . That is, pJun qIF levels in deafened unstimulated cochleae are not significantly different between P32 and P60 rats (Mann-Whitney U test). ES (high and low rate combined) suppressed Jun phosphorylation in SGNs in P32 cochleae, but not in P60 cochleae (Figures 5B, 5C ). In SGNs in deafened rat cochleae at P32, pJun qIF was reduced relative to unstimulated contralateral cochlea. The effect was significant over SGNs in all turns (Wilcoxon matched-pairs signedranks, P = .010) and in RC3 (Wilcoxon matched-pairs signedranks, P = .008) but not evident in the basal region. These data imply that an anti-apoptotic effect of ES diminishes rapidly with time after hair cell loss and is less evident in the base where SGNs die sooner. We note that apoptotic signaling, manifested as Jun phosphorylation, is highest in the base after deafening and that increased Jun phosphorylation is harder to reverse by ES in basal SGNs that have higher levels of Jun phosphorylation prior to ES.
Because some cochlear implant ES strategies involve rates as high as 5 kHz, we compared the ability of 5 kHz ES to that of 100 Hz ES to reduce Jun phosphorylation. As previously described, pairwise comparisons were used between the stimulated and contralateral unstimulated cochlea in each deafened rat. As shown in Figure 6A , 100 Hz ES significantly (Wilcoxon matched-pairs signed-ranks, P = .027, h 2 = .24) suppressed Jun phosphorylation in SGNs relative to contralateral unstimulated cochlea when all cochlear locations were averaged (All). In contrast, there was no significant change in pJun qIF with 5 kHz ES ( Figure 6B) .
To test the possibility that round window cochleostomy affects Jun phosphorylation, we assessed pJun qIF in hearing and deafened rats (P32 and P60) subjected to a surgical protocol identical to the one used to insert an electrode into stimulated subjects. As shown in Figure 7 , the procedure did not result in increased pJun qIF in the cochleae of either hearing ( Figure 7A ) or deafened ( Figure 7B ) rats.
Comparison of eABR threshold before and after stimulation of the same rat reveals a significant (n = 22, Wilcoxon matched-pairs signed-ranks, P = .001, h 2 = .65) increase in threshold after high (n = 6, Wilcoxon matched-pairs signedranks, P = .016, h 2 = .91) or low rate (n = 7, Wilcoxon matched-pairs signed-ranks, P = .047, h 2 = .62) ES with no significant difference between them (Figures 8A, 8B) . Wave 1 amplitude in response to a 0.6 mA stimulus decreased significantly after high rate ES ( Figure 8C, 8D ) (n = 6, Wilcoxon matched-pairs signed-ranks, P = .031, h 2 = .96). Of the 18 ES subjects used for the pJun qIF determinations, one subject for which there was no growth function measurement at 0.6 mA was excluded. Five additional subjects not used for pJun qIF study were included for a total of 22 subjects.
Conclusions
The MAP kinase JNK plays an essential role in neuronal apoptosis by phosphorylating Jun. [28] [29] [30] [31] Jun phosphorylation occurs in apoptotic SGNs 21 after aminoglycoside exposure during the period of SGN death. 32 Four hours of acute intracochlear ES decreased pJun immunoreactivity, consistent with a hypothesis that ES inhibits apoptosis. This effect was significant in SGNs peri-apical to the stimulus (RC3), but not in basal regions (RC1, RC2). While insertion trauma may affect SGN survival, 33 lack of suppression of Jun phosphorylation adjacent to the electrode is unlikely to be due to surgical trauma because pJun levels were not significantly increased in control operated but unstimulated rats. Lack of suppression of Jun phosphorylation in basal turn SGNs, in which Jun phosphorylation is highest, is consistent with the possibility that the ability of ES to suppress Jun phosphorylation in SGNs declines as SGN death becomes more advanced.
The ability of ES to promote SGN viability may also be affected by duration and etiology of deafness 5, 15, 34 and the closely related variable, number of surviving SGNs. Preimplantation duration of deafness has been shown to be an important predictor of SGN viability in animals, 35, 36 auditory cortex activation in animals 37 and humans, 38 and implant performance in human subjects. 39 Here, pJun qIF was unaffected by duration of deafness in unstimulated cochleae but ES was effective in suppressing Jun phosphorylation in rats deafened for 2 to 3 weeks but not in rats deafened for 6 to 7 weeks. It is unclear whether this is due to the smaller number of SGNs or to another consequence of longer post-deafening duration. Experiments in which deafening procedures result in substantial loss of SGNs prior to electrode implantation show no significant survivalpromoting effect of ES. 16, 40 Possibly, increased paracrine neurotrophic support from more ganglion cells may facilitate potential anti-apoptotic effects of ES as does exogenous neurotrophic factor. 18 Stimulus parameters such as pulse rate, amplitude, and stimulus configuration have been varied clinically to achieve maximum effectiveness in transmitting discriminable auditory signals, 41 as well as experimentally to assess effects on cortical activation. 42 High pulse rate stimulation has been proposed as a means of causing a more stochastic activation of SGNs 43 and increasing neural excitability. 44 However 200 Hz ES is more effective than 1000 Hz ES in preventing SGN death after hair cell loss. 45 Moreover, here, as in previous studies, 46 high rate ES tends to suppress eABR more than low rate. These findings are consistent with our observation that low rate ES is more effective than is high rate in suppressing Jun phosphorylation.
Some studies have found that ES in vivo reduces SGN death after hair cell loss. 33, 34, 45, 47 Other studies have not supported a survival-promoting effect of ES but have found that ES potentiates the survival-promoting effect of the neurotrophic factor BDNF. 48 Consistent with these observations, we show here that ES can suppress a known proapoptotic intracellular signaling pathway, the JNK-Jun pathway. The effectiveness of such suppression, however, depends on proximity to the electrode, preexisting level of Jun phosphorylation, duration of deafness, and stimulus rate. These observations may help explain why different studies have come to different conclusions regarding the efficacy of ES in preventing SGN death in vivo.
Summary
Acute patterned intracochlear electrical stimulation suppresses phosphorylation of Jun, a pro-apoptotic transcription factor in rat spiral ganglion neurons. This is consistent with studies showing that ES can, alone or with other trophic factors, slow the death of deafferented SGNs. We show that this effect is significant only for ES administered relatively early after deafening and for low rate (100 Hz) rather than high rate (5 kHz) ES.
